A New Alzheimer’s Risk Platform Aims to Read the Disease More Like a Map Than a Single Test
A New Alzheimer’s Risk Platform Aims to Read the Disease More Like a Map Than a Single Test For years, much of Alzheimer’s research has revolved around two headline molecules: amyloid and tau. They remain central to the disease. But the science is in...
Read more







